View in EDS

Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

Saved in:
Bibliographic Details
Title: Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.
Authors: Hobbs E; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Ulrich L; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Sharma A; Department of Medical Oncology, Mount Vernon Hospital, London, UK., Sherpa G; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Howlett S; Department of Medical Oncology, Mount Vernon Hospital, London, UK., Maxwell A; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Short D; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Vazquez I; Department of Medical Oncology, Mount Vernon Hospital, London, UK., Agarwal R; Medical Oncology, University Hospitals of Northamptonshire NHS Trust, London, UK., Hrouda D; Department of Urology, Charing Cross Hospital Campus of Imperial College London, London, UK., Mannion E; Department of Histopathology, Charing Cross Hospital Campus of Imperial College London, London, UK., Wilkes EH; Department of North West London Pathology, Charing Cross Hospital Campus of Imperial College London, London, UK., Lozano-Kuehne J; Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Maher E; Department of Surgery and Cancer, Imperial College London, London, UK., Rustin G; Department of Medical Oncology, Mount Vernon Hospital, London, UK., Tin T; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Gonzalez M; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Sarwar N; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Seckl MJ; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK., Ghorani E; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK. e.ghorani@imperial.ac.uk.
Source: British journal of cancer [Br J Cancer] 2026 May 28. Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42203894
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hobbs+E%22">Hobbs E</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ulrich+L%22">Ulrich L</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink>; Department of Medical Oncology, Mount Vernon Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Sherpa+G%22">Sherpa G</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Howlett+S%22">Howlett S</searchLink>; Department of Medical Oncology, Mount Vernon Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Maxwell+A%22">Maxwell A</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Short+D%22">Short D</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Vazquez+I%22">Vazquez I</searchLink>; Department of Medical Oncology, Mount Vernon Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Agarwal+R%22">Agarwal R</searchLink>; Medical Oncology, University Hospitals of Northamptonshire NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Hrouda+D%22">Hrouda D</searchLink>; Department of Urology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mannion+E%22">Mannion E</searchLink>; Department of Histopathology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Wilkes+EH%22">Wilkes EH</searchLink>; Department of North West London Pathology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lozano-Kuehne+J%22">Lozano-Kuehne J</searchLink>; Biostatistics Research Group, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Maher+E%22">Maher E</searchLink>; Department of Surgery and Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rustin+G%22">Rustin G</searchLink>; Department of Medical Oncology, Mount Vernon Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Tin+T%22">Tin T</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gonzalez+M%22">Gonzalez M</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sarwar+N%22">Sarwar N</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Seckl+MJ%22">Seckl MJ</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ghorani+E%22">Ghorani E</searchLink>; Department of Medical Oncology, Charing Cross Hospital Campus of Imperial College London, London, UK. e.ghorani@imperial.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 May 28. <i>Date of Electronic Publication: </i>2026 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42203894
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-026-03464-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hobbs E
      – PersonEntity:
          Name:
            NameFull: Ulrich L
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Sherpa G
      – PersonEntity:
          Name:
            NameFull: Howlett S
      – PersonEntity:
          Name:
            NameFull: Maxwell A
      – PersonEntity:
          Name:
            NameFull: Short D
      – PersonEntity:
          Name:
            NameFull: Vazquez I
      – PersonEntity:
          Name:
            NameFull: Agarwal R
      – PersonEntity:
          Name:
            NameFull: Hrouda D
      – PersonEntity:
          Name:
            NameFull: Mannion E
      – PersonEntity:
          Name:
            NameFull: Wilkes EH
      – PersonEntity:
          Name:
            NameFull: Lozano-Kuehne J
      – PersonEntity:
          Name:
            NameFull: Maher E
      – PersonEntity:
          Name:
            NameFull: Rustin G
      – PersonEntity:
          Name:
            NameFull: Tin T
      – PersonEntity:
          Name:
            NameFull: Gonzalez M
      – PersonEntity:
          Name:
            NameFull: Sarwar N
      – PersonEntity:
          Name:
            NameFull: Seckl MJ
      – PersonEntity:
          Name:
            NameFull: Ghorani E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1